Fresenius SE & Co KGaA (FRA:FRE) Receives €58.52 Average Price Target from Analysts

Shares of Fresenius SE & Co KGaA (FRA:FRE) have been assigned a consensus rating of “Buy” from the twenty analysts that are covering the company, MarketBeat reports. Nine analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is €58.52 ($68.04).

Several equities analysts have recently commented on the company. Deutsche Bank set a €65.00 ($75.58) target price on Fresenius SE & Co KGaA and gave the company a “buy” rating in a report on Wednesday, July 31st. Barclays set a €52.00 ($60.47) price objective on Fresenius SE & Co KGaA and gave the company a “neutral” rating in a research report on Thursday, July 18th. Credit Suisse Group set a €50.00 ($58.14) price objective on Fresenius SE & Co KGaA and gave the company a “neutral” rating in a research report on Thursday, July 18th. Nord/LB set a €58.00 ($67.44) price objective on Fresenius SE & Co KGaA and gave the company a “buy” rating in a research report on Wednesday, July 31st. Finally, Goldman Sachs Group set a €53.00 ($61.63) price objective on Fresenius SE & Co KGaA and gave the company a “buy” rating in a research report on Monday.

FRA FRE traded up €0.52 ($0.60) on Friday, hitting €45.69 ($53.13). 1,257,454 shares of the stock traded hands. The stock has a 50-day moving average of €44.04 and a 200 day moving average of €47.38. Fresenius SE & Co KGaA has a twelve month low of €60.16 ($69.95) and a twelve month high of €80.00 ($93.02).



About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Featured Story: What is the definition of a trade war?

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.